Mirum Pharmaceuticals Inc’s recently made public that its Officer CHRISTOPHER PEETZ acquired Company’s shares for reported $2.48 million on Aug 11 ’25. In the deal valued at $62.00 per share,40,000 shares were bought.
Then, Howe Jolanda sold 10,000 shares, generating $580,000 in total proceeds. Upon selling the shares at $58.00, the SVP, GLOBAL CONTROLLER now owns 2,426 shares.
Before that, Peetz Christopher sold 40,000 shares. Mirum Pharmaceuticals Inc shares valued at $2,210,040 were divested by the CHIEF EXECUTIVE OFFICER at a price of $55.25 per share. As a result of the transaction, Peetz Christopher now holds 138,641 shares, worth roughly $9.13 million.
Stifel began covering MIRM with “Buy” recommendation on April 17, 2024. H.C. Wainwright maintained its rating on December 18, 2023. It rated MIRM as “a Buy”.
Price Performance Review of MIRM
On Monday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock jump 9.84% to $65.87. Over the last five days, the stock has gained 26.09%. Mirum Pharmaceuticals Inc shares have risen nearly 69.07% since the year began. Nevertheless, the stocks have risen 59.30% over the past one year. While a 52-week high of $61.00 was reached on 08/11/25, a 52-week low of $36.86 was recorded on 04/09/25.
Levels Of Support And Resistance For MIRM Stock
The 24-hour chart illustrates a support level at 60.77, which if violated will result in even more drops to 55.66. On the upside, there is a resistance level at 68.69. A further resistance level may holdings at 71.50.
How much short interest is there in Mirum Pharmaceuticals Inc?
A steep rise in short interest was recorded in Mirum Pharmaceuticals Inc stocks on 2025-07-15, growing by 0.36 million shares to a total of 6.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 6.22 million shares. There was a rise of 5.51%, which implies that there is a positive sentiment for the stock.
